Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 84, 108444
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 60 references indexed in Scilit:
- Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal PhytochemicalsCurrent Pharmacology Reports, 2015
- Expression Profile of Histone Deacetylase 1 in Gastric Cancer TissuesJapanese Journal of Cancer Research, 2001
- hSIR2SIRT1 Functions as an NAD-Dependent p53 DeacetylaseCell, 2001
- Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylationProceedings of the National Academy of Sciences, 2000
- Histone Deacetylases Specifically Down-regulate p53-dependent Gene ActivationJournal of Biological Chemistry, 2000
- The language of covalent histone modificationsNature, 2000
- Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53Oncogene, 1999
- Major DNA Fragmentation Is a Late Event in ApoptosisJournal of Histochemistry & Cytochemistry, 1997
- Antioxidant, Gallic Acid, Induces Apoptosis in HL-60RG CellsBiochemical and Biophysical Research Communications, 1994
- In vitro sensitivity assays in cancer: A review, analysis, and prognosisJournal of Clinical Laboratory Analysis, 1991